Short-Term Intensive Treatment for Donors with Hepatic Steatosis in Living-Donor Liver Transplantation

Abstract

The results of this study indicate that our short-term treatment effectively reduced steatosis and contributed to safer LDLT. Our findings also suggest that even severely steatotic livers can be used for LDLT grafting subsequent to our short-term treatment regimen.